PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Michael S Niederman Selected Research
Pneumonia (Pneumonitis)
04/2008
Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes--proceedings of the HCAP Summit.
01/2006
Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy.
11/2005
A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia.
07/2005
Challenges in the management of community-acquired pneumonia: the role of quinolones and moxifloxacin.
08/2004
Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
07/2004
Hospitalization rates among patients with community-acquired pneumonia treated with telithromycin vs clarithromycin: results from two randomized, double-blind, clinical trials.
05/2004
Comparison of hospitalization rates in patients with community-acquired pneumonia treated with 10 days of telithromycin or clarithromycin.
01/2004
Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia.
03/2003
Bronchoalveolar interleukin-1 beta: a marker of bacterial burden in mechanically ventilated patients with community-acquired pneumonia.
02/2003
Granulocyte colony-stimulating factor for severe pneumonia: what do we do when the best laid plans for men (and mice and rats...) fail?
Articles by Research Topic
Disease
10
Pneumonia (Pneumonitis)
04/2008 - 02/2003
2
Chronic Bronchitis
10/2004 - 02/2004
1
Ventilator-Associated Pneumonia (Pneumonia, Ventilator Associated)
11/2004
1
Hysteria
09/2003
Drug/Important Bio-Agent (IBA)
4
Anti-Bacterial Agents (Antibiotics)
IBA
11/2004 - 09/2003
3
moxifloxacin (Avelox)
FDA Link
01/2006 - 07/2005
3
Ofloxacin (Levofloxacin)
FDA Link
Generic
01/2006 - 01/2004
3
telithromycin (Ketek)
FDA Link
08/2004 - 05/2004
3
Clarithromycin (Biaxin)
FDA Link
Generic
08/2004 - 05/2004
1
CPDD protocol (CHAP)
IBA
04/2008
1
Quinolones
IBA
07/2005
1
antineoplaston A10 (A 10)
IBA
08/2004
1
Antibodies
IBA
02/2004
1
Azithromycin (Zithromax)
FDA Link
Generic
01/2004
1
Ceftriaxone (Ceftriaxon)
FDA Link
Generic
01/2004
1
Interleukin-1beta (Interleukin 1 beta)
IBA
03/2003
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
02/2003